Safety monitoring of artemisinin combination therapy through a national pharmacovigilance system in an endemic malaria setting

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Thiam, Sylla ^a   Ndiaye, Jean Louis ^b   Diallo, Ibrahima ^c   Gatonga, Patrick ^a   Fall, Fatou B A ^c   Diallo, Ndella E ^b   Faye, Babacar ^b   Diouf, Mamadou L ^c   Ndiop, Medoune ^c   Diouf, Mame B ^c   Gaye, Oumar ^b   Thior, Moussa ^c  

^a AMREF HEALTH AFRICA   (Kenya)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c National Malaria Control Programme   (Senegal)

Author keywords

ACT; Malaria; Pharmacovigilance; Senegal

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ARTEMISININ; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; CIPROFLOXACIN; FALCIMON; PARACETAMOL; UNCLASSIFIED DRUG; WINTHROP;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; CHILD; CONFUSION; DIARRHEA; DRUG COST; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MISUSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DYSPNEA; EDEMA; EXTRAPYRAMIDAL SYNDROME; FAINTNESS; FATIGUE; GASTROINTESTINAL DISEASE; HEALTH CARE FACILITY; HICCUP; HOSPITALIZATION; HUMAN; HYPOTENSION; INFANT; INSOMNIA; MAJOR CLINICAL STUDY; MALAISE; MALARIA; MOTOR DYSFUNCTION; MYALGIA; NAUSEA; PRESCHOOL CHILD; PRURITUS; PUBLIC HEALTH SERVICE; SCHOOL CHILD; SOMNOLENCE; STIFF NECK; TINNITUS; TREMOR; URTICARIA; VERTIGO; VISUAL DISORDER; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; DRUG TOXICITY; ENDEMIC DISEASES; FEMALE; HUMANS; INFANT; MALARIA; MALE; MIDDLE AGED; PHARMACOVIGILANCE; SENEGAL; YOUNG ADULT;

EID: 84873252301     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-54     Document Type: Article

References (16)

1. Programme National de Lutte contre le Paludisme, Directives pour le traitement du paludisme au Sénégal Sénégal-Dakar: Ministère de la Santé et de la Prévention 2006
2. Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa. Zwang J, Dorsey G, Djimdé A, Karema C, Mårtensson A, Ndiaye J, Sirima SB, Olliaro P, Malar J 2012 11 260 10.1186/1475-2875-11-260 22856598
3. Pharmacovigilance of antimalarial treatment in Africa: is it possible? Talisuna AO, Staedke SG, D'Alesandro U, Malar J 2006 5 50 10.1186/1475-2875-5-50 16780575 (Pubitemid 44141482)
4. The WHO 'Roll back malaria Project': planning for adverse event monitoring in Africa. Simooya O, Drug Saf 2005 28 277 286 10.2165/00002018- 200528040-00001 15783238 (Pubitemid 40545764)
5. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin based combination therapy, to the WHO programme for international drug monitoring. Kuemmerle A, Dodoo A, Olsson A, Erps JV, Burri C, Lalvani PS, Malar J 2011 10 57 10.1186/1475-2875-10-57 21388536
6. A situational analysis of pharmacovigilance plans in the global fund malaria and U.S. President's Malaria initiative proposals. Stergachis A, Bartlein R, Dodoo A, Nwokike J, Kachur P, Malar J 2010 9 148 10.1186/1475-2875-9-148 20509971
7. Centre Marocain de Pharmacovigilance, Manuel sur les bonnes pratiques de pharmacovigilance Rabat: Ministère de la Santé 2011
8. World Health Organization, Guidelines on safety monitoring of herbal medicines in pharmacovigilance systems Geneva, Switzerland 2004
9. International statistical classification of diseases and related health problems 10th revision 2010 ICD-10) http://apps.who.int/classifications/icd10/ browse/2010/en.
10. Treatment of malaria outside the formal health services. Foster S, J Trop Med Hyg 1995 98 29 34 7861477
11. Conceptual framework of public health surveillance and action and its application in health sector reform. McNabb SJ, Chugging S, Ryan M, Wuhib T, Nsubuga P, Alemu W, Carande-Kulis V, Rodier G, BMC Public Health 2002 2 2 10.1186/1471-2458-2-2 11846889
12. Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics. Setel PW, Sankoh O, Rao C, Velkoff VA, Mathers C, Gonghuan Y, Hemed Y, Jha P, Lopez AD, Bull World Health Organ 2005 83 611 617 16184280 (Pubitemid 41169513)
13. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Martensson A, Stromberg J, Sisowath C, Msellem MI, Gil JP, Montgomery SM, Olliaro P, Ali AS, Björkman A, Clin Infect Dis 2005 41 1079 1086 10.1086/444460 16163624 (Pubitemid 41429468)
14. Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria. Ndiaye JL, Faye B, Diouf AM, Kuete T, Cisse M, Seck PA, Malar J 2008 7 16 10.1186/1475-2875-7-16 18205945 (Pubitemid 351328665)
15. Efficacy and safety of artesunate-amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Senegal. Brasseur P, Agnamey P, Cisse M, Eldin De P, Gaye O, Vaillant M, Taylor W, Olliaro P, Malar J 2007 6 150 10.1186/1475-2875-6-150 18005408 (Pubitemid 351143782)
16. Artesunate- and amodiaquine-associated extrapyramidal reactions: a series of 49 cases in VigiBase. Mc Ewen J, Drug Saf 2012 35 667 675 22788236